Gestaclone
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H27ClO2 |
| Molar mass | 370.92 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Gestaclone (INN, USAN) (developmental code name SH-1040), also known as 6-chloro-1α,2α:16α,17-bismethylene-4,6-pregnadiene-3,20-dione, is a steroidal progestin of unique chemical structure derived from progesterone that was first described in 1967 and was never marketed.[1]
Synthesis
References
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 595. ISBN 978-1-4757-2085-3.
- ^ Lednicer D, Mitscher LA (1980). The organic chemistry of drug synthesis. 2. Wiley. p. 168. ISBN 978-0-471-04392-8.
- ^ US 3441647, Neumann F, Wiechert R, "1,2-alpha,16,17-alpha-bismethylene-delta-4,6-pregnadienes", issued 1969-04-29, assigned to Schering AG and Bayer Pharma AG
- ^ DE 1286033, Gries H, Heinz J, "Process for the production of α,β-methylene ketones of the steriod series", published 1969-01-02, assigned to Schering AG and Bayer Pharma AG